Fatty acid, dyslipidaemia and insulin resistance - Preface

Fatty acid, dyslipidaemia and insulin resistance - Preface

Bibliografski detalji
Glavni autori:	Karpe, F, Coppack, S
Format:	Journal article
Izdano:	2002

Slični predmeti

Journal of the Royal Society of Medicine: Preface
od: Karpe, F, i dr.
Izdano: (2002)

Fatty acids, obesity, and insulin resistance: time for a reevaluation.
od: Karpe, F, i dr.
Izdano: (2011)

Metabolic Syndrome: Insulin Resistance, Obesity, Diabetes Mellitus, Hypertension, Physical Activity and Genetic Factors
od: Coppack, S, i dr.
Izdano: (2008)

Adipose tissue fatty acid metabolism in insulin-resistant men.
od: Bickerton, A, i dr.
Izdano: (2008)

Triglycerides and atherogenic dyslipidaemia: extending treatment beyond statins in the high-risk cardiovascular patient.
od: Watts, G, i dr.
Izdano: (2011)

Interaction Among Sex, Aging, and Epigenetic Processes Concerning Visceral Fat, Insulin Resistance, and Dyslipidaemia
od: Ana Arpón, i dr.
Izdano: (2019-07-01)

Oscillations of fatty acid and glycerol release from human subcutaneous adipose tissue in vivo.
od: Karpe, F, i dr.
Izdano: (2005)

Insulin plant (Costus pictus) extract improves insulin sensitivity and ameliorates atherogenic dyslipidaemia in fructose induced insulin resistant rats: Molecular mechanism
od: S. Ashwini, i dr.
Izdano: (2015-08-01)

Fatty acid-induced mitochondrial uncoupling in adipocytes is not a promising target for treatment of insulin resistance unless adipocyte oxidative capacity is increased.
od: Frayn, K, i dr.
Izdano: (2008)

Republished review: Triglycerides and atherogenic dyslipidaemia: extending treatment beyond statins in the high-risk cardiovascular patient.
od: Watts, G, i dr.
Izdano: (2011)

Insulin resistance reduces the contribution of systemic plasma non-esterified fatty acids into very low-density lipoprotein triacylglycerol
od: Hodson, L, i dr.
Izdano: (2007)

Insulin resistance, adipose tissue and coronary heart disease.
od: Frayn, K, i dr.
Izdano: (1992)

Secondary dyslipidaemia
od: D.J. Blom
Izdano: (2011-07-01)

Diabetic dyslipidaemia
od: Subashini C. Thambiah, i dr.
Izdano: (2021-08-01)

Interaction between specific fatty acids, GLP-1 and insulin secretion in humans.
od: Beysen, C, i dr.
Izdano: (2002)

The Effect of Omega-3 Fatty Acids on Insulin Resistance
od: Susmita Sinha, i dr.
Izdano: (2023-06-01)

Lysophosphatidylcholine as an effector of fatty acid-induced insulin resistance[S]
od: Myoung Sook Han, i dr.
Izdano: (2011-06-01)

Association of nonalcoholic fatty liver with carotid intima-media thickness in patients with dyslipidaemia
od: Hamid Dehdashti Shahroukh, i dr.
Izdano: (2018-09-01)

Dyslipidaemia in endocrine disorders
od: Kalyani Sridharan, i dr.
Izdano: (2024-03-01)

Treatment of Dyslipidaemia in Children
od: Riccardo Fiorentino, i dr.
Izdano: (2021-08-01)

Dyslipidaemia in Sri Lanka
od: Anne Thushara Matthias, i dr.
Izdano: (2022-01-01)

Advances on the treatment of Dyslipidaemias
od: Eleni Bilianou
Izdano: (2017-01-01)

Short term fat feeding rapidly increases plasma insulin but does not result in dyslipidaemia
od: Benjamin eBarzel, i dr.
Izdano: (2014-12-01)

Risk factors, comorbiditiEs and Atherogenic dysLipidaemia in Indian YOUNG patients with dyslipidaemia attending hospital/clinic: REAL YOUNG (dyslipidaemia) study
od: S S Iyengar, i dr.
Izdano: (2020-01-01)

Truncation of Pik3r1 causes severe insulin resistance uncoupled from obesity and dyslipidaemia by increased energy expenditure
od: Albert Kwok, i dr.
Izdano: (2020-10-01)

Insulin resistance by adiponectin deficiency: is the action in skeletal muscle?
od: Karpe, F
Izdano: (2013)

Adipose tissue fatty acid metabolism in insulin-resistant men (Diabetologia DOI: 10.1007/s00125-008-1040-x)
od: Bickerton, A, i dr.
Izdano: (2008)

New concepts in the management of dyslipidaemia
od: Baris Gencer, i dr.
Izdano: (2016-11-01)

Dyslipidaemia in elderly and stroke patients
od: Dhiman Kahali
Izdano: (2024-03-01)

Managing dyslipidaemia in young adults
od: Jamshed J. Dalal, i dr.
Izdano: (2024-03-01)

Role of statins in the management of dyslipidaemia
od: Saumitra Ray
Izdano: (2024-03-01)

The changing paradigm of dyslipidaemia management
od: Ruvan Ekanayaka
Izdano: (2017-04-01)

Update on the Management of Diabetic Dyslipidaemia
od: Iciar Martín-Timón, i dr.
Izdano: (2018-11-01)

Adipose tissue function in the insulin-resistance syndrome.
od: Karpe, F, i dr.
Izdano: (2005)

Omega-3 fatty acids, insulin resistance and type 2 diabetes
od: Leila Azadbakht, i dr.
Izdano: (2011-01-01)

Insulin and non-esterified fatty acid relations to alimentary lipaemia and plasma concentrations of postprandial triglyceride-rich lipoproteins in healthy middle-aged men.
od: Boquist, S, i dr.
Izdano: (2000)

Hypertension and Dyslipidaemia in Argentina: Patient Journey Stages
od: Sadler AE, i dr.
Izdano: (2022-10-01)

Seasonal variation lipid levels in the patients with dyslipidaemia
od: I V Radysh, i dr.
Izdano: (2009-12-01)

Emerging Strategies for the Management of Atherogenic Dyslipidaemia
od: Anandita Agarwala, i dr.
Izdano: (2020-02-01)

Established and Emerging Approaches for the Management of Dyslipidaemia
od: Giuseppe Danilo Norata
Izdano: (2012-01-01)